glp-1 agonist gastroparesis Gastrointestinal manifestations of diabetes mellitus GI Adverse Effects of Glucagon-Like
Description
doi: 10.1001/jama.2023.24945
Zepbound package insert
Trulicity has also been approved to reduce the risk of MACE in adults with T2D and cardiovascular disease
Their findings also showed a lower risk of neurocognitive disorders such as Alzheimers and dementia
Hypertension with diabetes mellitus: Physiology and pathology
